Ranked by engagement
Top topics — this week page 9
Ranked by replies, likes and views over this week, with a bonus for topics that reached a marked solution. Engagement is a proxy for usefulness and a poor one; the documentation commons is the better index of what is settled.
314 topics · page 9 of 11
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
A comparison of home results against a laboratory result on the same vial — does this still hold?
A comparison of home results against a laboratory result on the same vial — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Working through the…
|
+2 | 6 | 15k | 11h |
|
About the Reconstitution category
Diluent choice, volumes, resulting concentrations, worked examples, and the errors we see most often. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is…
|
+1 | 5 | 15k | 16h |
|
Follow-up: External review after an internal denial
Posting this under the heading it deserves: External review after an internal denial Everything below is what sits behind that. A coverage question with the paperwork detail included, since that is what…
|
+6 | 10 | 12k | 15h |
|
When your prescriber and the evidence disagree
When your prescriber and the evidence disagree — that is the question, and I have not found it answered plainly anywhere I have looked. General question, not a request for advice about my own care — I know…
|
+14 | 18 | 273 | 2d |
|
Revisiting: Drawing from a pen cartridge with a syringe: how the risk profile changes
Revisiting: Drawing from a pen cartridge with a syringe: how the risk profile changes Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained page on this…
|
2 | 18k | 6h | |
|
Sleep apnoea improving and the equipment implications
Sleep apnoea improving and the equipment implications Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The published…
|
+14 | 18 | 1.1k | 17h |
|
Distinguishing a red flag from an inconvenience — a second dataset
On the subject in the title: Distinguishing a red flag from an inconvenience — a second dataset Working notes rather than a conclusion. A logistics question, since the answers here are usually better than…
|
+8 | 12 | 9.6k | 1d |
|
Repeatability versus intermediate precision — what changed since
Posting this under the heading it deserves: Repeatability versus intermediate precision — what changed since Everything below is what sits behind that. Working through the identity arithmetic and I would like…
|
4 | 21k | 5h | |
|
Why side effects reset at each escalation and that is not a failure
Why side effects reset at each escalation and that is not a failure — that is the question, and I have not found it answered plainly anywhere I have looked. I have read the maintained page on this and I still…
|
+3 | 7 | 11k | 14h |
|
Coming back to: Light exposure: how much protection is proportionate?
Asking directly, because I could not find a straight answer: Light exposure: how much protection is proportionate? Practical question with the units stated, because I have seen how quickly these go wrong…
|
+5 | 10 | 13k | 2d |
|
A 40-week log with the measurement method stated — what changed since
A 40-week log with the measurement method stated — what changed since Writing it up because I had to work it out twice and would rather nobody else did. Longitudinal report with the method stated, because a…
|
+9 | 13 | 2.1k | 9h |
|
A structured critique template this community uses
A structured critique template this community uses — setting out what I have, and where I think it stops being reliable. Comparing SURMOUNT-2 ( Lancet , 2023) with SURPASS-4 ( Lancet , 2021) and finding the…
|
2 | 18k | 1d | |
|
Impurity thresholds: where the common numbers come from
Impurity thresholds: where the common numbers come from — setting out what I have, and where I think it stops being reliable. A documentation question rather than an analytical one. I have a certificate in…
|
+11 | 15 | 825 | 2d |
|
About the Adverse events category
Serious and unexpected events, how to document them, and where to report them officially. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its…
|
+2 | 6 | 8.7k | 2d |
|
Second pass at: Orforglipron as a non-peptide: what changes when the molecule is small
Second pass at: Orforglipron as a non-peptide: what changes when the molecule is small Writing it up because I had to work it out twice and would rather nobody else did. Comparing SURPASS-4 ( Lancet , 2021)…
|
2 | 17k | 6h | |
|
Dizziness on standing: the ordinary explanation first — one year on
Dizziness on standing: the ordinary explanation first — one year on — setting out what I have, and where I think it stops being reliable. Longitudinal report with the method stated, because a number without a…
|
+12 | 16 | 1.1k | 2d |
|
What consumer-accessible tests can and cannot determine
What consumer-accessible tests can and cannot determine — that is the question, and I have not found it answered plainly anywhere I have looked. Posting the method first, because I know what the first three…
|
2 | 17k | 1h | |
|
About the Comorbidities category
Type 2 diabetes, hepatic steatosis, sleep apnoea, cardiovascular and renal disease. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author…
|
4 | 16k | 12h | |
|
BPC-157: what the rodent literature actually shows, and what it does not — does this still hold?
The question in the title: BPC-157: what the rodent literature actually shows, and what it does not — does this still hold? I will give what I have already checked below so nobody repeats it. I have seen…
|
+6 | 10 | 3.1k | 1d |
|
[2026 update] Journal club: what we got wrong in an earlier session
Journal club: what we got wrong in an earlier session — setting out what I have, and where I think it stops being reliable. I have seen STEP 4 ( JAMA , 2021) cited in support of a claim I do not think it…
|
+5 | 9 | 4.2k | 1d |
|
Why pulsatile secretion matters for interpreting secretagogue claims
Why pulsatile secretion matters for interpreting secretagogue claims — that is the question, and I have not found it answered plainly anywhere I have looked. I have seen SURPASS-2 ( N Engl J Med , 2021) cited…
|
+5 | 9 | 1.6k | 15h |
|
Cost versus information: making the trade-off explicitly
Cost versus information: making the trade-off explicitly Writing it up because I had to work it out twice and would rather nobody else did. Working through the identity arithmetic and I would like it checked.…
|
+2 | 6 | 12k | 11h |
|
About the Shortages category
Supply interruptions, official shortage notices, and managing an unplanned gap. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author and…
|
+3 | 7 | 9.9k | 1d |
|
A site rotation scheme that is easy enough to actually follow — a second dataset
A site rotation scheme that is easy enough to actually follow — a second dataset Writing it up because I had to work it out twice and would rather nobody else did. Practical question with the units stated,…
|
+6 | 10 | 1.2k | 7h |
|
What published stability data actually covers, and what it does not
Asking directly, because I could not find a straight answer: What published stability data actually covers, and what it does not Reporting something rather than asking about it, in case the pattern is useful…
|
+8 | 12 | 435 | 1d |
|
Coming back to: Why I now write the concentration on the vial in marker
The question in the title: Why I now write the concentration on the vial in marker I will give what I have already checked below so nobody repeats it. Practical question with the units stated, because I have…
|
+8 | 12 | 4.3k | 1d |
|
Adolescents: a distinct evidence base
Adolescents: a distinct evidence base Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The published trials in this…
|
3 | 11k | 9h | |
|
Mobile reading experience on long topics
Mobile reading experience on long topics Writing it up because I had to work it out twice and would rather nobody else did. Nominating something for promotion into the documentation commons. The topic in…
|
2 | 14k | 4h | |
|
Coming back to: How much context is too much context in a first post?
Asking directly, because I could not find a straight answer: How much context is too much context in a first post? Question in the title. Context below, and I have tried to include the things people here…
|
+2 | 6 | 7.5k | 1d |
|
The report format the maintainers ask for, and why each field is there
On the subject in the title: The report format the maintainers ask for, and why each field is there Working notes rather than a conclusion. Structured report rather than an opinion, following the format the…
|
4 | 6.3k | 1d |